Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Insiders Buying Walt Disney And 3 Other Stocks

Author: Avi Kapoor | December 11, 2023 08:17am

Although U.S. stocks closed higher on Friday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

Nextracker

  • The Trade: Nextracker Inc. (NASDAQ:NXT) CEO Daniel Shugar acquired a total of 37,821 shares an average price of $39.63. To acquire these shares, it cost around $1.5 million.
  • What’s Happening: On Oct. 25, NEXTracker posted upbeat quarterly results.
  • What Nextracker Does: NEXTracker Inc provides integrated solar tracker and software solutions used in utility-scale and ground-mounted distributed solar generation projects worldwide. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance.

Olema Pharmaceuticals

  • The Trade: Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) 10% owner Senai Asefaw acquired a total of 100,000 shares at an average price of $11.60. To acquire these shares, it cost around $1.16 million
  • What’s Happening: Olema Pharmaceuticals recently announced interim results from an ongoing Phase 1b/2 clinical study of palazestrant in combination with CDK4/6 inhibitor ribociclib..
  • What Olema Pharmaceuticals Does: Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company.

Don’t forget to check out our premarket coverage here

Walt Disney

  • The Trade: The Walt Disney Company (NYSE:DIS) Director Amy Chang bought a total of 1,078 shares at an average price of $92.69. To acquire these shares, it cost around $99,918.
  • What’s Happening: The Walt Disney recently begun the beta launch of its integrated Hulu and Disney+ streaming experience, marking a significant move in the streaming industry.
  • What Walt Disney Does: Disney operates in three global business segments: entertainment, sports, and experiences.

Heartland Express

  • The Trade: Heartland Express, Inc. (NASDAQ:HTLD) 10% owner Julie Durr bought a total of 182,268 shares at an average price of $13.72. The insider spent around $2.5 million to buy those shares.
  • What’s Happening: On Oct. 26, Heartland Express posted weak quarterly results.
  • What Heartland Express Does: Heartland Express Inc is engaged in providing truckload services across the United States and Canada.

 

Check This Out: This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'

Posted In: DIS HTLD NXT OLMA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist